speb/financial-data huggingface dataset:
Financial ratios for ACMR — quarterly report dated 2025-03-31
Total revenue: 172347000
Gross profit: 82550000
Operating income: 25777000
Net income: 25013000
Capital expenditures: 16726000
Operating cash flow: 5282000
Depreciation & amortization: 3017000
Net tangible assets: 946149000
Owner earnings: 11304000
Return on net tangible assets (%): 1.1947378267059416
Capex to operating income (%): 64.8873026341312
Buffett classification: The Good
Stock price: 23.34
P/E ratio: 14.957288488585935
Shares outstanding: 64117679
Book value: 1155353000
P/B ratio: 1.2952808603604264
Market cap (USD): 1496506627.86
Debt to equity: 0.2052524206887419
Current ratio: 2.4613263621878967
Quick ratio: 1.4920334309675327
Effective tax rate (%): 7.925347861297209
Interest coverage ratio: 16.544929396662386
COGS to revenue (%): 52.10244448699426
R&D to revenue (%): 15.957922099021161
SG&A to revenue (%): 16.983179283654486
Free cash flow (dilution-adjusted): -21636000
Buyback yield (%): 0
Retained earnings: 280380000
Inventory turnover: 0.14731276463456847
Receivables turnover: 0.4075370242067255
Capitalized R&D asset: 27503000
ROCI (R&D-adjusted, %): 3.3107599134289463
FCF margin (%): -12.55374332016223
Rule of 40 score: -12.55374332016223
Financial ratios for ACMR — quarterly report dated 2025-06-30
Total revenue: 215372000
Gross profit: 104461000
Operating income: 31694000
Net income: 36270000
Capital expenditures: 14046000
Operating cash flow: -44901000
Depreciation & amortization: 3339000
Net tangible assets: 983601000
Owner earnings: 25563000
Return on net tangible assets (%): 2.598919683896214
Capex to operating income (%): 44.317536442228814
Buffett classification: The Good
Stock price: 25.9
P/E ratio: 27.098018799667116
Shares outstanding: 64117679
Book value: 1191689000
P/B ratio: 1.39352455724606
Market cap (USD): 1660647886.1
Debt to equity: 0.24114764842169392
Current ratio: 2.452494143174787
Quick ratio: 1.486374312232866
Effective tax rate (%): 4.955320877335499
Interest coverage ratio: 18.03870233352305
COGS to revenue (%): 51.49740913396356
R&D to revenue (%): 15.701669669223485
SG&A to revenue (%): 18.084987835001765
Free cash flow (dilution-adjusted): -69812000
Buyback yield (%): 0
Retained earnings: 310140000
Inventory turnover: 0.17108555280296417
Receivables turnover: 0.4511636675953663
Capitalized R&D asset: 52244010
ROCI (R&D-adjusted, %): 3.171898718446932
Rosenberg metric: 0.7966767261753264
FCF margin (%): -32.41461285589585
Revenue growth (%): 24.964171119891844
Rule of 40 score: -7.450441736004002
Financial ratios for ACMR — quarterly report dated 2025-09-30
Total revenue: 269160000
Gross profit: 113149000
Operating income: 28923000
Net income: 46398000
Capital expenditures: 11011000
Operating cash flow: -4625000
Depreciation & amortization: 4104000
Net tangible assets: 1429974000
Owner earnings: 39491000
Return on net tangible assets (%): 2.761658603583002
Capex to operating income (%): 38.070048058638456
Buffett classification: The Good
Stock price: 39.13
P/E ratio: 23.299605123187938
Shares outstanding: 64117679
Book value: 1885214000
P/B ratio: 1.3308434900600146
Market cap (USD): 2508924779.27
Debt to equity: 0.15756513584134216
Current ratio: 3.4787871992966193
Quick ratio: 2.4809410077758387
Effective tax rate (%): 5.478028805997514
Interest coverage ratio: 15.625607779578607
COGS to revenue (%): 57.96217862981127
R&D to revenue (%): 14.731386535889435
SG&A to revenue (%): 16.560781691187398
Free cash flow (dilution-adjusted): -23198000
Buyback yield (%): 0
Retained earnings: 346029000
Inventory turnover: 0.23064595533175933
Receivables turnover: 0.5103081642480937
Capitalized R&D asset: 71384380
ROCI (R&D-adjusted, %): 1.6134216572448825
Rosenberg metric: 0.25691220392110475
FCF margin (%): -8.618665477782733
Revenue growth (%): 24.97446278996341
Rule of 40 score: 16.355797312180677
Financial ratios for ACMR — quarterly report dated 2025-12-31
Total revenue: 244430000
Gross profit: 99907000
Operating income: 23035000
Net income: 14212000
Capital expenditures: 13124000
Operating cash flow: 33919000
Depreciation & amortization: 5868000
Net tangible assets: 1461516000
Owner earnings: 6956000
Return on net tangible assets (%): 0.4759441566154596
Capex to operating income (%): 56.97416974169742
Buffett classification: The Good
Stock price: 39.45
P/E ratio: 20.75133466687997
Shares outstanding: 64117679
Book value: 1930509000
P/B ratio: 1.3102463840106418
Market cap (USD): 2529442436.55
Debt to equity: 0.15431577889561768
Current ratio: 3.2675885596584204
Quick ratio: 2.32536019267492
Effective tax rate (%): 31.60073154297815
Interest coverage ratio: 12.875908328675237
COGS to revenue (%): 59.12653929550382
R&D to revenue (%): 18.00842777073191
SG&A to revenue (%): 13.441066972139263
Free cash flow (dilution-adjusted): 13089000
Buyback yield (%): 0
Retained earnings: 350428000
Inventory turnover: 0.205688334275032
Receivables turnover: 0.44208317884627557
Capitalized R&D asset: 81743780
ROCI (R&D-adjusted, %): 1.2630553418763533
Rosenberg metric: -0.33396383445562533
FCF margin (%): 5.354907335433457
Revenue growth (%): -9.187843661762521
Rule of 40 score: -3.8329363263290643
Financial ratios for ACMR — annual report dated 2025-12-31
Total revenue: 901309000
Gross profit: 400067000
Operating income: 109429000
Net income: 121893000
Capital expenditures: 55597000
Operating cash flow: -10325000
Depreciation & amortization: 16328000
Net tangible assets: 1461516000
Owner earnings: 82624000
Return on net tangible assets (%): 5.653307935048265
Capex to operating income (%): 50.80645898253662
Buffett classification: The Good
Stock price: 39.45
P/E ratio: 20.75133466687997
Shares outstanding: 64117679
Book value: 1930509000
P/B ratio: 1.3102463840106418
Market cap (USD): 2529442436.55
Debt to equity: 0.15431577889561768
Current ratio: 3.2675885596584204
Quick ratio: 2.32536019267492
Effective tax rate (%): 9.837120539676905
Interest coverage ratio: 15.733860531991374
COGS to revenue (%): 55.61267001660918
R&D to revenue (%): 16.08649197999798
SG&A to revenue (%): 16.159718808976724
Free cash flow (dilution-adjusted): -101557000
Buyback yield (%): 0.2762664174137598
Retained earnings: 350428000
Inventory turnover: 0.7133787151435106
Receivables turnover: 1.6301335672493467
Capitalized R&D asset: 246249880
ROCI (R&D-adjusted, %): 5.901560095659662
Rosenberg metric: 0.08071259943303026
FCF margin (%): -11.267722834233322
Revenue growth (%): 15.239516287823577
Rule of 40 score: 3.971793453590255
Financial ratios for AGN.AS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.897727272727273
Shares outstanding: 1470418770
Market cap (USD): 5731291342.159091
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AGN.AS — annual report dated 2022-12-31
Total revenue: -23024468085.106384
Net income: -574468085.106383
Capital expenditures: 67021276.595744684
Operating cash flow: 2842553191.489362
Depreciation & amortization: 179787234.04255322
Net tangible assets: 10997872340.425533
Owner earnings: -461702127.65957445
Return on net tangible assets (%): -4.198104082027471
Buffett classification: The Gruesome
Stock price: 4.1063829787234045
Shares outstanding: 1470418770
Book value: 11632978723.404236
P/B ratio: 0.5190504300137183
Market cap (USD): 6038102608.723405
Debt to equity: 0.6103337905807051
Effective tax rate (%): 8.585247883917775
Free cash flow (dilution-adjusted): 2738297872.3404255
Buyback yield (%): 10.518310537836316
Retained earnings: 8265957446.808511
Receivables turnover: -2.754613720249459
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AGN.AS — annual report dated 2023-12-31
Total revenue: 22284444444.444443
Net income: -198888888.8888889
Capital expenditures: 21111111.111111112
Operating cash flow: 960000000
Depreciation & amortization: 14444444.444444444
Net tangible assets: 9913333333.333334
Owner earnings: -205555555.55555555
Return on net tangible assets (%): -2.073526115220802
Buffett classification: The Gruesome
Stock price: 5.033333333333333
Shares outstanding: 1470418770
Book value: 10615555555.555542
P/B ratio: 0.6971945811283241
Market cap (USD): 7401107809
Debt to equity: 0.5146535482520417
COGS to revenue (%): 0
SG&A to revenue (%): 9.408655763861189
Free cash flow (dilution-adjusted): 831111111.111111
Buyback yield (%): 16.09368680811107
Retained earnings: 5665555555.555555
Receivables turnover: 5.622652088589851
Capitalized R&D asset: 0
FCF margin (%): 3.7295572397287597
Rule of 40 score: 3.7295572397287597
Financial ratios for AGN.AS — annual report dated 2024-12-31
Total revenue: 20332291666.666668
Net income: 716666666.6666667
Capital expenditures: 32291666.666666668
Operating cash flow: 793750000
Depreciation & amortization: 17708333.333333336
Net tangible assets: 8970833333.333334
Owner earnings: 702083333.3333335
Return on net tangible assets (%): 7.826288899210406
Buffett classification: The Gruesome
Stock price: 5.447916666666667
P/E ratio: 11.177747335901163
Shares outstanding: 1470418770
Book value: 9701041666.666626
P/B ratio: 0.8257586349296717
Market cap (USD): 8010718924.0625
Debt to equity: 0.5363470417695717
Effective tax rate (%): -2.4242424242424248
COGS to revenue (%): 0
SG&A to revenue (%): 10.15933193298837
Free cash flow (dilution-adjusted): 725000000
Buyback yield (%): 12.02815472369642
Retained earnings: 4528125000
Receivables turnover: 5.096344647519582
Capitalized R&D asset: 0
FCF margin (%): 3.5657564424406987
Revenue growth (%): -8.760159054646975
Rule of 40 score: -5.194402612206276
Financial ratios for AGN.AS — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 8970833333.333334
Buffett classification: The Gruesome
Stock price: 5.447916666666667
Shares outstanding: 1470418770
Book value: 9701041666.666626
P/B ratio: 0.8257586349296717
Market cap (USD): 8010718924.0625
Debt to equity: 0.5363470417695717
Buyback yield (%): 0
Retained earnings: 4528125000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AGN.AS — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 10274117647.058825
Buffett classification: The Gruesome
Stock price: 6.823529411764706
Shares outstanding: 1470418770
Book value: 11045882352.941162
P/B ratio: 0.908342620726383
Market cap (USD): 10033445724.705881
Debt to equity: 0.45457450207689915
Buyback yield (%): 0
Retained earnings: 4803529411.764706
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKAL.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.02272727272727
Shares outstanding: 15460337
Market cap (USD): 556923503.2954545
Buyback yield (%): 0
Retained earnings: -17176136.363636363
Capitalized R&D asset: 3768181.8181818184
Rule of 40 score: 0
Financial ratios for ALKAL.PA — annual report dated 2022-12-31
Total revenue: 17461702.127659574
Gross profit: 22475531.91489362
Operating income: -20851063.829787236
Net income: -16540425.531914895
Capital expenditures: 1556382.9787234042
Operating cash flow: -1825531.9148936172
Depreciation & amortization: 18621276.59574468
Net tangible assets: 16900000
Owner earnings: 524468.085106381
Buffett classification: The Gruesome
Stock price: 18.4468085106383
Shares outstanding: 15460337
Book value: 57463829.78723404
P/B ratio: 4.963015469120261
Market cap (USD): 285193876.14893615
Debt to equity: 0.1233893661137441
Current ratio: 1.7229461335709246
Quick ratio: 1.6462857779262723
Interest coverage ratio: -133.33333333333334
COGS to revenue (%): -28.713293529913493
SG&A to revenue (%): 4.319483367856708
Free cash flow (dilution-adjusted): -17593617.021276597
Buyback yield (%): 0
Retained earnings: -16540425.531914895
Inventory turnover: -2.2823244552058113
Receivables turnover: 4.4579033134166215
Capitalized R&D asset: 2524681.8181818184
ROCI (R&D-adjusted, %): -32.73519825098495
FCF margin (%): -100.7554526623614
Rule of 40 score: -100.7554526623614
Financial ratios for ALKAL.PA — annual report dated 2023-12-31
Total revenue: 28698888.888888888
Gross profit: 32956666.666666664
Operating income: -18021111.111111112
Net income: -12991111.11111111
Capital expenditures: 5128888.888888889
Operating cash flow: -2384444.4444444445
Depreciation & amortization: 16837777.777777776
Net tangible assets: 16338888.888888888
Owner earnings: -1282222.222222223
Return on net tangible assets (%): -7.847670860251619
Buffett classification: The Gruesome
Stock price: 23.055555555555554
Shares outstanding: 15460337
Book value: 62940000
P/B ratio: 5.6632770672245165
Market cap (USD): 356446658.6111111
Debt to equity: 0.05774458920312114
Current ratio: 1.689251119675034
Quick ratio: 1.469690657223206
Interest coverage ratio: -163.82828282828282
COGS to revenue (%): -14.836037012660189
SG&A to revenue (%): 4.27426536064114
Free cash flow (dilution-adjusted): -25218888.888888888
Buyback yield (%): 0
Inventory turnover: -0.9089184060721064
Receivables turnover: 2.4847522847522847
Capitalized R&D asset: 1243500
ROCI (R&D-adjusted, %): -27.788405136378962
FCF margin (%): -87.87409500948546
Revenue growth (%): 64.353329813303
Rule of 40 score: -23.520765196182452
Financial ratios for ALKAL.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -19247916.666666668
Buffett classification: The Gruesome
Stock price: 1.09375
Shares outstanding: 15460337
Book value: 40694791.66666667
P/B ratio: 0.41552598996595586
Market cap (USD): 16909743.59375
Debt to equity: 0.21870120562111242
Current ratio: 0.6999140869661613
Quick ratio: 0.5907213923454258
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKAL.PA — annual report dated 2024-12-31
Total revenue: 25858333.333333336
Gross profit: 29637500
Operating income: -30753125
Net income: -24235416.666666668
Capital expenditures: 9530208.333333334
Operating cash flow: 2941666.666666667
Depreciation & amortization: 20927083.333333336
Net tangible assets: -19247916.666666668
Owner earnings: -12838541.666666666
Buffett classification: The Gruesome
Stock price: 1.09375
Shares outstanding: 15460337
Book value: 40694791.66666667
P/B ratio: 0.41552598996595586
Market cap (USD): 16909743.59375
Debt to equity: 0.21870120562111242
Current ratio: 0.6999140869661613
Quick ratio: 0.5907213923454258
Interest coverage ratio: -57.104448742746605
COGS to revenue (%): -14.614888817273606
SG&A to revenue (%): 6.723332259104092
Free cash flow (dilution-adjusted): -31155208.333333336
Buyback yield (%): 15.42503183961582
Inventory turnover: -0.9208121827411168
Receivables turnover: 3.295804567180032
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -56.713923467035485
FCF margin (%): -120.48420883016435
Revenue growth (%): -9.897789306593353
Rule of 40 score: -130.38199813675772
Financial ratios for ALSEI.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.625
Shares outstanding: 22567115
Market cap (USD): 14104446.875
Buyback yield (%): 0.12815912969743
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALSEI.PA — annual report dated 2022-12-31
Total revenue: 37240197.872340426
Gross profit: 23135902.127659574
Operating income: 2107181.914893617
Net income: 2659467.021276596
Capital expenditures: 31987.234042553195
Operating cash flow: -521935.10638297873
Depreciation & amortization: 6171176.595744682
Net tangible assets: 4900776.595744682
Owner earnings: 8798656.382978724
Return on net tangible assets (%): 179.53596151717161
Capex to operating income (%): 1.5180100880928498
Buffett classification: The Great
Stock price: 0.29787234042553196
P/E ratio: 2.5276189958074307
Shares outstanding: 22567115
Book value: 7583300.000000004
P/B ratio: 0.8864372188495938
Market cap (USD): 6722119.361702128
Debt to equity: 0.28268555400711126
Current ratio: 0.5554672492464818
Quick ratio: 0.5414244301378954
Effective tax rate (%): -108.68106568543648
COGS to revenue (%): 37.8738474833846
Free cash flow (dilution-adjusted): -1636150
Buyback yield (%): 0.059789907318047265
Retained earnings: 1609186.1702127662
Inventory turnover: 85.61637413305436
Receivables turnover: 14.257878314052402
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.651293878228344
FCF margin (%): -4.393505119410831
Rule of 40 score: -4.393505119410831
Financial ratios for ALSEI.PA — annual report dated 2023-12-31
Total revenue: 33923863.333333336
Gross profit: 18228302.22222222
Operating income: -2811596.6666666665
Net income: -2653377.7777777775
Capital expenditures: 79762.22222222222
Operating cash flow: 2746396.6666666665
Depreciation & amortization: 5858055.555555555
Net tangible assets: -12165876.666666666
Owner earnings: 3124915.5555555555
Buffett classification: The Gruesome
Stock price: 0.2777777777777778
Shares outstanding: 22567115
Book value: -2313510
Market cap (USD): 6268643.055555556
Debt to equity: -1.72035709088499
Current ratio: 0.5390428654056254
Quick ratio: 0.5281559235377705
Interest coverage ratio: -19.802300739523417
COGS to revenue (%): 46.26702140875791
Free cash flow (dilution-adjusted): -3043686.6666666665
Buyback yield (%): 0
Retained earnings: -8517845.555555556
Inventory turnover: 92.65141279252806
Receivables turnover: 11.46076463963964
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -76.93896023854862
FCF margin (%): -8.972110979105267
Revenue growth (%): -8.905254881769158
Rule of 40 score: -17.877365860874427
Financial ratios for ALSEI.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -13624455.208333334
Buffett classification: The Gruesome
Stock price: 0.2604166666666667
Shares outstanding: 22567115
Book value: -3988966.666666668
Market cap (USD): 5876852.864583334
Debt to equity: -0.962367290192113
Current ratio: 0.48333941489650606
Quick ratio: 0.4654995798125656
Buyback yield (%): 0
Retained earnings: -9788238.541666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALSEI.PA — annual report dated 2024-12-31
Total revenue: 32600952.083333336
Gross profit: 19049280.208333336
Operating income: -1012032.2916666667
Net income: -1802756.25
Capital expenditures: 20812.5
Operating cash flow: 5103845.833333334
Depreciation & amortization: 4918559.375
Net tangible assets: -13624455.208333334
Owner earnings: 3094990.625
Buffett classification: The Gruesome
Stock price: 0.2604166666666667
Shares outstanding: 22567115
Book value: -3988966.666666668
Market cap (USD): 5876852.864583334
Debt to equity: -0.962367290192113
Current ratio: 0.48333941489650606
Quick ratio: 0.4654995798125656
Interest coverage ratio: -3.7171338824888758
COGS to revenue (%): 41.5683316252842
Free cash flow (dilution-adjusted): -182833.33333333334
Buyback yield (%): 0
Retained earnings: -9788238.541666668
Inventory turnover: 46.10931535688843
Receivables turnover: 11.801249622926095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -50.25709174916537
FCF margin (%): -0.5608220669935701
Revenue growth (%): -3.8996479764146357
Rule of 40 score: -4.460470043408206
Financial ratios for ALTA.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 129.92045454545453
Shares outstanding: 24739226
Market cap (USD): 3214131487.022727
Buyback yield (%): 1.1066187541421613
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALTA.PA — annual report dated 2022-12-31
Total revenue: 3147659574.4680853
Gross profit: 817021276.5957447
Operating income: 298723404.2553192
Net income: 451595744.6808511
Capital expenditures: 2659574.4680851065
Operating cash flow: 209255319.14893618
Depreciation & amortization: 33404255.31914894
Net tangible assets: 2160638297.8723407
Owner earnings: 482340425.53191495
Return on net tangible assets (%): 22.323978335795175
Capex to operating income (%): 0.8903133903133903
Buffett classification: The Great
Stock price: 97.98936170212767
P/E ratio: 5.368033231707892
Shares outstanding: 24739226
Book value: 4212340425.5319157
P/B ratio: 0.575495026482473
Market cap (USD): 2424180964.744681
Debt to equity: 0.7079502980098998
Current ratio: 1.5848734152060728
Quick ratio: 1.124120662930726
Effective tax rate (%): 13.859577922077923
Interest coverage ratio: 5.924050632911393
COGS to revenue (%): 74.0435311612816
SG&A to revenue (%): 1.6831147762606462
Free cash flow (dilution-adjusted): 172659574.4680851
Buyback yield (%): 1.1541516005263284
Retained earnings: 347659574.4680851
Inventory turnover: 1.8897610627102566
Receivables turnover: 8.521889400921658
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.272932010469291
FCF margin (%): 5.485331891307286
Rule of 40 score: 5.485331891307286
Financial ratios for ALTA.PA — annual report dated 2023-12-31
Total revenue: 2944777777.7777777
Gross profit: 594888888.8888888
Operating income: -175777777.77777776
Net income: -525444444.4444444
Capital expenditures: 8888888.888888888
Operating cash flow: 367222222.2222222
Depreciation & amortization: 140444444.44444445
Net tangible assets: 1531111111.1111112
Owner earnings: -393888888.8888889
Return on net tangible assets (%): -25.725689404934688
Buffett classification: The Gruesome
Stock price: 70.75555555555556
Shares outstanding: 24739226
Book value: 3577333333.333334
P/B ratio: 0.4893135518946452
Market cap (USD): 1750437679.6444445
Debt to equity: 0.830910672133184
Current ratio: 1.2661925601750548
Quick ratio: 0.8502188183807439
Interest coverage ratio: -2.215686274509804
COGS to revenue (%): 79.79851337584425
Free cash flow (dilution-adjusted): 328777777.7777778
Buyback yield (%): 0.3491190336094926
Retained earnings: -525444444.4444444
Inventory turnover: 1.8541995440995969
Receivables turnover: 8.11730474732006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.827474039784811
FCF margin (%): 11.164773799192545
Revenue growth (%): -6.445480900665444
Rule of 40 score: 4.719292898527101
Financial ratios for ALTA.PA — annual report dated 2024-12-31
Total revenue: 2822708333.3333335
Gross profit: 616666666.6666667
Operating income: 216354166.6666667
Net income: 89687500
Capital expenditures: 28020833.333333336
Operating cash flow: 450312500
Depreciation & amortization: 49270833.333333336
Net tangible assets: 1390729166.6666667
Owner earnings: 110937500
Return on net tangible assets (%): 7.976930566998726
Capex to operating income (%): 12.95137217140106
Buffett classification: The Great
Stock price: 86.375
P/E ratio: 23.825512426480838
Shares outstanding: 24739226
Book value: 3294687500
P/B ratio: 0.6485746055581902
Market cap (USD): 2136850645.75
Debt to equity: 0.8675582535015335
Current ratio: 1.2529997736019922
Quick ratio: 0.8786129348728396
Effective tax rate (%): -14.49468085106383
Interest coverage ratio: 2.1635416666666667
COGS to revenue (%): 78.15336925234335
Free cash flow (dilution-adjusted): 400208333.3333334
Buyback yield (%): 0.0487477526208229
Retained earnings: 6354166.666666667
Inventory turnover: 2.1344486998588996
Receivables turnover: 8.99966788442378
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6122995582455046
FCF margin (%): 14.178168130489336
Revenue growth (%): -4.145285439384212
Rule of 40 score: 10.032882691105124
Financial ratios for ALTA.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1390729166.6666667
Buffett classification: The Gruesome
Stock price: 86.375
Shares outstanding: 24739226
Book value: 3294687500
P/B ratio: 0.6485746055581902
Market cap (USD): 2136850645.75
Debt to equity: 0.8675582535015335
Current ratio: 1.2529997736019922
Quick ratio: 0.8786129348728396
Buyback yield (%): 0
Retained earnings: 6354166.666666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALTA.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1380470588.235294
Buffett classification: The Gruesome
Stock price: 110.07058823529412
Shares outstanding: 24739226
Book value: 3487411764.705882
P/B ratio: 0.7808258221367609
Market cap (USD): 2723061158.3058825
Debt to equity: 0.845832068279189
Current ratio: 1.2091400662829235
Quick ratio: 0.7791732077446364
Buyback yield (%): 0
Retained earnings: 11176470.588235294
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APUS — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -2663904
Net income: -2662193
Capital expenditures: 13369
Operating cash flow: -3361096
Depreciation & amortization: 232
Net tangible assets: 9737679
Owner earnings: -2675330
Return on net tangible assets (%): -27.47400073467199
Buffett classification: The Gruesome
Stock price: 17.6
Shares outstanding: 1509117
Book value: 9737679
P/B ratio: 2.727596504259383
Market cap (USD): 26560459.200000003
Debt to equity: 0.05134693801264141
Current ratio: 12.792983206469206
Quick ratio: 12.792983206469206
Interest coverage ratio: -115.55062028281426
Free cash flow (dilution-adjusted): -5266518
Buyback yield (%): 0
Retained earnings: -7456514
Capitalized R&D asset: 651784
ROCI (R&D-adjusted, %): -21.458099743300817
Rule of 40 score: 0
Financial ratios for APUS — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -1844239
Net income: -1781255
Capital expenditures: 22540
Operating cash flow: -1726166
Depreciation & amortization: 1489
Net tangible assets: 8160652
Owner earnings: -1802306
Return on net tangible assets (%): -22.08531867306681
Buffett classification: The Gruesome
Stock price: 17.8
Shares outstanding: 1509117
Book value: 8160652
P/B ratio: 3.291683385102073
Market cap (USD): 26862282.6
Debt to equity: 0.061269614241607165
Current ratio: 8.340592481622641
Quick ratio: 8.340592481622641
Interest coverage ratio: -292.6898904935725
Free cash flow (dilution-adjusted): -1791380
Buyback yield (%): 0
Retained earnings: -9237769
Capitalized R&D asset: 1056388.28
ROCI (R&D-adjusted, %): -17.88395858748126
Rule of 40 score: 0
Financial ratios for APUS — annual report dated 2025-12-31
Total revenue: 0
Operating income: -11912562
Net income: -6001137
Capital expenditures: 57333
Operating cash flow: -8925777
Depreciation & amortization: 5706
Net tangible assets: 153347827
Owner earnings: -6052764
Return on net tangible assets (%): -3.9470816890023492
Buffett classification: The Gruesome
Stock price: 16.4
Shares outstanding: 1509117
Book value: 153347827
P/B ratio: 0.16139464956357025
Market cap (USD): 24749518.799999997
Debt to equity: 0.050606488215838887
Current ratio: 1.3061147690808956
Quick ratio: 1.3061147690808956
Interest coverage ratio: -42.092222563787274
Free cash flow (dilution-adjusted): -12248916
Buyback yield (%): 0
Retained earnings: -10393061
Capitalized R&D asset: 1665100.52
ROCI (R&D-adjusted, %): -6.998102362678404
Rule of 40 score: 0
Financial ratios for APUS — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -7040051
Net income: -1155292
Capital expenditures: 21424
Operating cash flow: -3818202
Depreciation & amortization: 3985
Net tangible assets: 153347827
Owner earnings: -1172731
Return on net tangible assets (%): -0.764752277839581
Buffett classification: The Gruesome
Stock price: 16.4
Shares outstanding: 1509117
Book value: 153347827
P/B ratio: 0.16139464956357025
Market cap (USD): 24749518.799999997
Debt to equity: 0.050606488215838887
Current ratio: 1.3061147690808956
Quick ratio: 1.3061147690808956
Interest coverage ratio: -32.64966330278633
Free cash flow (dilution-adjusted): -5170705
Buyback yield (%): 0
Retained earnings: -10393061
Capitalized R&D asset: 991387.03
ROCI (R&D-adjusted, %): -4.676120250654217
Rule of 40 score: 0
Financial ratios for ARGH.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7165354330708662
Shares outstanding: 275031895
Market cap (USD): 197070097.992126
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARGH.V — annual report dated 2022-12-31
Total revenue: 40383291.9117647
Gross profit: -2985014.705882353
Operating income: -22537117.647058822
Net income: -24588585.294117644
Capital expenditures: 474748.5294117647
Operating cash flow: -12803088.235294117
Depreciation & amortization: 4517897.794117646
Net tangible assets: -1974988.2352941176
Owner earnings: -20545436.029411763
Buffett classification: The Gruesome
Stock price: 0.25735294117647056
Shares outstanding: 275031895
Book value: 338368.38235294074
P/B ratio: 209.1810901580033
Market cap (USD): 70780267.09558822
Debt to equity: 45.05608228066788
Current ratio: 0.4129547468968782
Quick ratio: 0.21161487866835046
Interest coverage ratio: -22.241195273185085
COGS to revenue (%): 107.39170722487026
R&D to revenue (%): 4.654991907781023
SG&A to revenue (%): 38.53933512871524
Free cash flow (dilution-adjusted): -17442095.588235293
Buyback yield (%): 0
Retained earnings: -66201667.64705882
Inventory turnover: 20.116837209238874
Receivables turnover: 82.38039146275794
Capitalized R&D asset: 1879838.9705882352
ROCI (R&D-adjusted, %): -144.52935074177614
FCF margin (%): -43.19136643527061
Rule of 40 score: -43.19136643527061
Financial ratios for ARGH.V — annual report dated 2023-12-31
Total revenue: 11238250
Gross profit: 314618.9393939394
Operating income: -7551743.181818182
Net income: 693973.4848484849
Capital expenditures: 90103.78787878787
Operating cash flow: -5697152.2727272725
Depreciation & amortization: 1051274.2424242424
Net tangible assets: 1391542.424242424
Owner earnings: 1655143.9393939395
Return on net tangible assets (%): 118.94311740405787
Buffett classification: The Gruesome
Stock price: 0.07575757575757576
P/E ratio: 30.023841077676316
Shares outstanding: 275031895
Book value: 1630497.7272727303
P/B ratio: 12.778766429845483
Market cap (USD): 20835749.62121212
Debt to equity: 6.129710810558393
Current ratio: 0.03505763960639944
Quick ratio: 0.03505763960639944
Effective tax rate (%): -0.7118409286201827
Interest coverage ratio: -35.78960955030967
COGS to revenue (%): 97.20046324477619
R&D to revenue (%): 4.09023161564705
SG&A to revenue (%): 47.09475688075558
Free cash flow (dilution-adjusted): -6222376.515151515
Buyback yield (%): 0
Retained earnings: -67513805.3030303
Receivables turnover: 43.69330867062919
Capitalized R&D asset: 1719162.5648395722
ROCI (R&D-adjusted, %): -73.60188429685077
Rosenberg metric: 1.7552746255940093
FCF margin (%): -55.367842103098916
Revenue growth (%): -72.1710403783947
Rule of 40 score: -127.5388824814936
Financial ratios for ARGH.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.14074074074074072
Shares outstanding: 275031895
Market cap (USD): 38708192.62962963
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARGH.V — annual report dated 2024-12-31
Total revenue: 1094311.1888111888
Gross profit: 929212.5874125875
Operating income: -6312969.93006993
Net income: -2611250.34965035
Capital expenditures: 317928.67132867133
Operating cash flow: -2135320.27972028
Depreciation & amortization: 271865.73426573427
Net tangible assets: 648739.8601398602
Owner earnings: -2657313.286713287
Return on net tangible assets (%): -409.6115330635616
Buffett classification: The Gruesome
Stock price: 0.09090909090909091
Shares outstanding: 275031895
Book value: 837040.5594405588
P/B ratio: 29.870594995020774
Market cap (USD): 25002899.545454547
Debt to equity: 5.206431583801743
Current ratio: 0.04923553997821739
Quick ratio: 0.04923553997821739
Interest coverage ratio: -4.455161396665469
COGS to revenue (%): 15.086988334456967
R&D to revenue (%): 92.92712150888416
SG&A to revenue (%): 509.1822617286476
Free cash flow (dilution-adjusted): -3060527.972027972
Buyback yield (%): 0
Retained earnings: -64931686.013986014
Receivables turnover: 2.0610044081641252
Capitalized R&D asset: 1945237.9529514604
ROCI (R&D-adjusted, %): -147.04547154607025
Rosenberg metric: 1.337031001103583
FCF margin (%): -279.6762021005007
Revenue growth (%): -90.26261927959256
Rule of 40 score: -369.93882138009326
Financial ratios for ARGH.V — quarterly report dated 2024-12-31
Total revenue: 1039859.4405594406
Gross profit: 263657.34265734267
Operating income: -3191817.4825174827
Net income: -401895.80419580423
Capital expenditures: 46127.97202797203
Operating cash flow: 348753.14685314684
Depreciation & amortization: 182997.2027972028
Net tangible assets: 648739.8601398602
Owner earnings: -265026.5734265735
Return on net tangible assets (%): -40.85251881539036
Buffett classification: The Gruesome
Stock price: 0.09090909090909091
Shares outstanding: 275031895
Book value: 837040.5594405588
P/B ratio: 29.870594995020774
Market cap (USD): 25002899.545454547
Debt to equity: 5.206431583801743
Current ratio: 0.04923553997821739
Quick ratio: 0.04923553997821739
Interest coverage ratio: -5.84082989633334
COGS to revenue (%): 12.125024966392042
R&D to revenue (%): 20.67257610798662
SG&A to revenue (%): 273.29211384809275
Free cash flow (dilution-adjusted): -148513.986013986
Buyback yield (%): 0
Retained earnings: -64931686.013986014
Receivables turnover: 1.9584510446176802
Capitalized R&D asset: 214965.73426573427
ROCI (R&D-adjusted, %): -115.81451781731162
FCF margin (%): -14.282121238817238
Rule of 40 score: -14.282121238817238
Financial ratios for ARGH.V — quarterly report dated 2025-03-31
Total revenue: 358162.2377622378
Gross profit: 277052.44755244756
Operating income: -2180260.13986014
Net income: -1205776.9230769232
Capital expenditures: 0
Operating cash flow: -1099107.6923076923
Depreciation & amortization: 31104.195804195806
Net tangible assets: 1078339.160839161
Owner earnings: -1174672.7272727275
Return on net tangible assets (%): -108.9335127510903
Buffett classification: The Gruesome
Stock price: 0.17482517482517484
Shares outstanding: 275031895
Book value: 1411211.1888111886
P/B ratio: 34.071795566175375
Market cap (USD): 48082499.12587413
Debt to equity: 3.006254112917932
Current ratio: 0.0988447443759305
Quick ratio: 0.0988447443759305
Interest coverage ratio: -7.296242558130827
COGS to revenue (%): 22.646103262185356
R&D to revenue (%): 43.83136914942637
SG&A to revenue (%): 596.6214474824864
Free cash flow (dilution-adjusted): -2207699.300699301
Buyback yield (%): 0
Retained earnings: -66137462.93706294
Receivables turnover: 0.5877576313977507
Capitalized R&D asset: 301014.4545454546
ROCI (R&D-adjusted, %): -66.26855219571763
Rosenberg metric: 0.06231274459094144
FCF margin (%): -616.3964449442766
Revenue growth (%): -65.55666816184814
Rule of 40 score: -681.9531131061248
Financial ratios for ARGH.V — quarterly report dated 2025-06-30
Total revenue: 272558.3941605839
Gross profit: 44103.64963503649
Operating income: -3901905.1094890507
Net income: -7967608.759124087
Capital expenditures: 1900419.7080291968
Operating cash flow: 6926013.138686131
Depreciation & amortization: 39215.32846715328
Net tangible assets: -3874687.5912408754
Owner earnings: -9828813.138686132
Buffett classification: The Gruesome
Stock price: 0.42335766423357657
Shares outstanding: 275031895
Book value: -3475085.4014598504
Market cap (USD): 116436860.65693429
Debt to equity: -1.206111407859116
Current ratio: 0.28041545044745675
Quick ratio: 0.28041545044745675
Interest coverage ratio: -15.220725158454012
COGS to revenue (%): 83.81864195712431
R&D to revenue (%): 106.17452899666581
SG&A to revenue (%): 1230.761505603835
Free cash flow (dilution-adjusted): 3976555.4744525547
Buyback yield (%): 0
Retained earnings: -77001602.91970803
Receivables turnover: 0.29284691385522227
Capitalized R&D asset: 465507.84998213465
Rosenberg metric: -1.4838692738355834
FCF margin (%): 1458.9737684283823
Revenue growth (%): -23.900856811845443
Rule of 40 score: 1435.0729116165369
Financial ratios for ARGH.V — quarterly report dated 2025-09-30
Total revenue: 81896.40287769785
Gross profit: -425451.7985611511
Operating income: -2927792.805755396
Net income: 2131558.273381295
Capital expenditures: 591509.3525179856
Operating cash flow: -2892046.762589928
Depreciation & amortization: 48115.10791366907
Net tangible assets: 1659347.4820143885
Owner earnings: 1588164.0287769786
Return on net tangible assets (%): 95.71015390031533
Buffett classification: The Gruesome
Stock price: 0.3597122302158274
P/E ratio: 11.603287787905359
Shares outstanding: 275031895
Book value: 2062000.0000000019
P/B ratio: 47.97882460278136
Market cap (USD): 98932336.33093527
Debt to equity: 0.1502452741977125
Current ratio: 0.1622731878677958
Quick ratio: 0.1622731878677958
Effective tax rate (%): 0
Interest coverage ratio: -25.94535045328777
COGS to revenue (%): 619.4999824308654
R&D to revenue (%): 249.64334656874803
SG&A to revenue (%): 2480.883024702203
Free cash flow (dilution-adjusted): -4506548.92086331
Buyback yield (%): 0
Retained earnings: -73885574.8201439
Receivables turnover: 0.08195849085674256
Capitalized R&D asset: 450144.4531485424
ROCI (R&D-adjusted, %): -106.47349042809284
Rosenberg metric: -1.6225832150672501
FCF margin (%): -5502.743420359113
Revenue growth (%): -69.95271302139874
Rule of 40 score: -5572.696133380512
Financial ratios for ARGH.V — quarterly report dated 2025-12-31
Total revenue: 882809.4890510949
Gross profit: 69753.28467153283
Operating income: -2419186.131386861
Net income: -4053361.313868613
Capital expenditures: 892610.2189781021
Operating cash flow: -661452.5547445255
Depreciation & amortization: 185837.22627737225
Net tangible assets: -864730.6569343065
Owner earnings: -4760134.3065693425
Buffett classification: The Gruesome
Stock price: 0.2773722627737226
Shares outstanding: 275031895
Book value: -437554.74452554807
Market cap (USD): 76286219.05109489
Debt to equity: -5.8747101509717154
Current ratio: 0.11182050660095952
Quick ratio: 0.11182050660095952
Interest coverage ratio: -4571.427586206896
COGS to revenue (%): 92.09871602688496
R&D to revenue (%): 116.49585885804197
SG&A to revenue (%): 151.82541802093348
Free cash flow (dilution-adjusted): -1820753.2846715327
Buyback yield (%): 0
Retained earnings: -79026433.57664233
Receivables turnover: 0.875992731017969
Capitalized R&D asset: 1260915.1784382712
ROCI (R&D-adjusted, %): -74.90122118812117
Rosenberg metric: 2.4221457425239654
FCF margin (%): -206.24532328357787
Revenue growth (%): 977.9588089716975
Rule of 40 score: 771.7134856881196
Financial ratios for ARGH.V — annual report dated 2025-12-31
Total revenue: 1612308.02919708
Gross profit: -28619.708029197078
Operating income: -11567371.532846715
Net income: -11116878.832116788
Capital expenditures: 3417590.510948905
Operating cash flow: 2183050.3649635036
Depreciation & amortization: 306336.49635036493
Net tangible assets: -864730.6569343065
Owner earnings: -14228132.846715327
Buffett classification: The Gruesome
Stock price: 0.2773722627737226
Shares outstanding: 275031895
Book value: -437554.74452554807
Market cap (USD): 76286219.05109489
Debt to equity: -5.8747101509717154
Current ratio: 0.11182050660095952
Quick ratio: 0.11182050660095952
Interest coverage ratio: -16.929120593271854
COGS to revenue (%): 101.77507694007141
R&D to revenue (%): 104.76412741040409
SG&A to revenue (%): 557.3839379734904
Free cash flow (dilution-adjusted): -4720922.627737226
Buyback yield (%): 0
Retained earnings: -79026433.57664233
Receivables turnover: 1.5998583287280512
Capitalized R&D asset: 2522142.652991169
ROCI (R&D-adjusted, %): -288.06717363403106
Rosenberg metric: -0.941902938336381
FCF margin (%): -292.8052544704015
Revenue growth (%): 47.33542393444959
Rule of 40 score: -245.46983053595193
Financial ratios for BGR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7
Shares outstanding: 25456171
Market cap (USD): 178193197
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BGR — annual report dated 2022-12-31
Total revenue: 114037967
Net income: 113787532
Capital expenditures: 0
Operating cash flow: 28409495
Net tangible assets: 398492584
Owner earnings: 113787532
Return on net tangible assets (%): 28.554491744318135
Buffett classification: The Gruesome
Stock price: 9.73
P/E ratio: 2.1767634773025923
Shares outstanding: 25456171
Book value: 398492584
P/B ratio: 0.621563747419701
Market cap (USD): 247688543.83
Debt to equity: 0.0002089900875043637
COGS to revenue (%): 0
SG&A to revenue (%): 0.14719483731238386
Free cash flow (dilution-adjusted): 28409495
Buyback yield (%): 4.859658752833324
Retained earnings: -126951863
Receivables turnover: 153.18068765976196
Capitalized R&D asset: 0
FCF margin (%): 24.91231275632965
Rule of 40 score: 24.91231275632965
Financial ratios for BGR — annual report dated 2023-12-31
Total revenue: 18564532
Net income: 18408670
Capital expenditures: 0
Operating cash flow: 29460140
Net tangible assets: 387981857
Owner earnings: 18408670
Return on net tangible assets (%): 4.7447244421019406
Buffett classification: The Gruesome
Stock price: 10.29
P/E ratio: 14.229382111255186
Shares outstanding: 25456171
Book value: 387981857
P/B ratio: 0.6751449709928059
Market cap (USD): 261943999.58999997
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 1.5284953049180017
Free cash flow (dilution-adjusted): 29460140
Buyback yield (%): 2.929454010021517
Retained earnings: -119498391
Receivables turnover: 15.28038086270275
Capitalized R&D asset: 0
FCF margin (%): 158.69045338713627
Revenue growth (%): -83.72074451309712
Rule of 40 score: 74.96970887403916
Financial ratios for BGR — annual report dated 2024-12-31
Total revenue: 14884135
Net income: 14142908
Capital expenditures: 0
Operating cash flow: 42619705
Net tangible assets: 359569775
Owner earnings: 14142908
Return on net tangible assets (%): 3.9332861055966117
Buffett classification: The Gruesome
Stock price: 11.12
P/E ratio: 20.01516389132984
Shares outstanding: 25456171
Book value: 359569775
P/B ratio: 0.7872536603500669
Market cap (USD): 283072621.52
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 2.216541303878257
Free cash flow (dilution-adjusted): 42619705
Buyback yield (%): 6.988132901649188
Retained earnings: -114232470
Receivables turnover: 41.708143718615496
Capitalized R&D asset: 0
FCF margin (%): 286.34317681208887
Revenue growth (%): -19.824884354747
Rule of 40 score: 266.5182924573419
Financial ratios for BGR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 359569775
Buffett classification: The Gruesome
Stock price: 11.12
Shares outstanding: 25456171
Book value: 359569775
P/B ratio: 0.7872536603500669
Market cap (USD): 283072621.52
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -114232470
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BGR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 352820598
Buffett classification: The Gruesome
Stock price: 12.24
Shares outstanding: 25456171
Book value: 352820598
P/B ratio: 0.8831217191009919
Market cap (USD): 311583533.04
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -111949541
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIOV.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 87343750
Buffett classification: The Gruesome
Stock price: 43.49999999999999
Shares outstanding: 5848011
Book value: 87343750
P/B ratio: 2.912497786046511
Market cap (USD): 254388478.49999997
Debt to equity: 0.26113774597495526
Current ratio: 9.23780129335685
Quick ratio: 9.23780129335685
Buyback yield (%): 0
Retained earnings: -113681250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLU.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -648611.7647058823
Net income: -656408.0882352941
Capital expenditures: 0
Operating cash flow: -539947.0588235294
Owner earnings: -656408.0882352941
Buffett classification: The Gruesome
Stock price: 0.10294117647058824
Shares outstanding: 72799915
Market cap (USD): 7494108.897058824
Free cash flow (dilution-adjusted): -539947.0588235294
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLU.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -241722.72727272726
Net income: -248895.45454545453
Capital expenditures: 503151.51515151514
Operating cash flow: 454568.9393939394
Net tangible assets: -446250.75757575757
Owner earnings: -752046.9696969697
Buffett classification: The Gruesome
Stock price: 0.03787878787878788
Shares outstanding: 72799915
Book value: -446250.75757575757
Market cap (USD): 2757572.537878788
Debt to equity: 0
Current ratio: 0.005171759573113518
Quick ratio: 0.005171759573113518
Free cash flow (dilution-adjusted): -48582.57575757575
Buyback yield (%): 0
Retained earnings: -1057528.7878787878
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLU.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.014814814814814814
Shares outstanding: 72799915
Market cap (USD): 1078517.259259259
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLU.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -258039.86013986016
Net income: -274778.3216783217
Capital expenditures: 400220.27972027974
Operating cash flow: -378725.17482517485
Net tangible assets: 2233614.6853146856
Owner earnings: -674998.6013986014
Return on net tangible assets (%): -30.22001090145516
Buffett classification: The Gruesome
Stock price: 0.02097902097902098
Shares outstanding: 72799915
Book value: 2233614.6853146856
P/B ratio: 0.6837665216374473
Market cap (USD): 1527270.9440559442
Debt to equity: 0
Current ratio: 1.8153625083184632
Quick ratio: 1.8153625083184632
Free cash flow (dilution-adjusted): -778945.4545454546
Buyback yield (%): 0
Retained earnings: -1436696.5034965035
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.552568213147556
Rule of 40 score: 0
Financial ratios for BLU.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -439695.1048951049
Net income: -460516.0839160839
Capital expenditures: 409834.26573426573
Operating cash flow: -406926.5734265734
Net tangible assets: 2233614.6853146856
Owner earnings: -870350.3496503497
Return on net tangible assets (%): -38.9660022998877
Buffett classification: The Gruesome
Stock price: 0.02097902097902098
Shares outstanding: 72799915
Book value: 2233614.6853146856
P/B ratio: 0.6837665216374473
Market cap (USD): 1527270.9440559442
Debt to equity: 0
Current ratio: 1.8153625083184632
Quick ratio: 1.8153625083184632
Free cash flow (dilution-adjusted): -816760.8391608392
Buyback yield (%): 0
Retained earnings: -1436696.5034965035
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.685360585510203
Rule of 40 score: 0
Financial ratios for BLU.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -96477.62237762238
Net income: -96476.92307692308
Capital expenditures: 0
Net tangible assets: -87213.98601398602
Owner earnings: -96476.92307692308
Buffett classification: The Gruesome
Stock price: 0.02097902097902098
Shares outstanding: 72799915
Book value: -87213.98601398602
Market cap (USD): 1527270.9440559442
Debt to equity: 0
Current ratio: 0.11533250576343324
Quick ratio: 0.11533250576343324
Buyback yield (%): 0
Retained earnings: -500862.2377622378
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLU.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -456345.2554744525
Net income: -3545608.759124087
Capital expenditures: 1836916.0583941604
Operating cash flow: -1464308.7591240874
Net tangible assets: 3895047.445255474
Owner earnings: -5382524.817518247
Return on net tangible assets (%): -138.1889410377955
Buffett classification: The Gruesome
Stock price: 0.3284671532846715
Shares outstanding: 72799915
Book value: 3895047.4452554747
P/B ratio: 6.1391757547250245
Market cap (USD): 23912380.839416057
Debt to equity: 0
Current ratio: 2.575757125808074
Quick ratio: 2.575757125808074
Free cash flow (dilution-adjusted): -3301224.8175182478
Buyback yield (%): 0
Retained earnings: -5282720.437956204
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.716038427986875
Rule of 40 score: 0